Simultaneous in-field boost for patients with 1 to 4 brain metastasis/es treated with volumetric modulated arc therapy: a prospective study on quality-of-life

PURPOSE: To assess treatment toxicity and patients' survival/quality of life (QoL) after volumetric modulated arc therapy (VMAT) with simultaneous in-field boost (SIB) for cancer patients with 1 - 4 brain metastases (BM) treated with or without surgery. METHODS AND MATERIALS: Between March and...

Descripción completa

Detalles Bibliográficos
Autores principales: Weber, Damien C, Caparrotti, Francesca, Laouiti, Mohamed, Malek, Karim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3158112/
https://www.ncbi.nlm.nih.gov/pubmed/21714935
http://dx.doi.org/10.1186/1748-717X-6-79

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3158112/
https://www.ncbi.nlm.nih.gov/pubmed/21714935
http://dx.doi.org/10.1186/1748-717X-6-79

Ejemplares similares